Polinsky Davidinsider trades

In SEC Form 4 filings, Polinsky David is listed as Chief Financial Officer of Rafael Holdings, Inc. (RFL) and Director of Ernexa Therapeutics Inc. (ERNA). Polinsky David reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 23.

Companies and roles

Company	Role	Transactions	Last filed
RFLRafael Holdings, Inc.	Chief Financial Officer	1	Sep 23
ERNAErnexa Therapeutics Inc.	Director	1	Sep 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RFLRafael Holdings, Inc.	Sep 21	Sep 23	F	2,027	$2.03	$4,105	297,084	No	Form 4
ERNAErnexa Therapeutics Inc.	Aug 31	Sep 1	A · derivative	5,083	$4.57	$23,229	5,083	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.